Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial
Hölger Thiele(Leipzig Heart Institute), Gerhard Schüler(Institut de Médecine de la Reproduction), Klaus Empen(Universität Greifswald), Marcus Hennersdorf(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Georg Fuernau(Leipzig Heart Institute), Rainer Hambrecht(Leipzig University of Applied Sciences), Jörg Hausleiter(LMU Klinikum), Hans‐Georg Olbrich(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Ingo Eitel(German Centre for Cardiovascular Research), Henning Ebelt(University Hospital in Halle), Uwe Zeymer(University of Freiburg), Mirosław Ferenc(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Steffen Desch(Leipzig Heart Institute), Steffen Schneider(Klinikum Ludwigshafen), Franz‐Josef Neumann(University of Freiburg), Gert Richardt(Badr University in Cairo), Bernward Lauer(Jena University Hospital), Michael Böhm(Saarland University), Antoinette de Waha(Deutsches Herzzentrum München), Karl Werdan(Universitäts-Herzzentrum Freiburg-Bad Krozingen)
Cited by 940
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k